Supplement Co. Hit With False Ad Case Over Weight Loss Pill

By Melissa Angell (March 25, 2021, 9:44 PM EDT) -- A dietary supplement manufacturer was hit with a proposed class action in California federal court on Wednesday, accusing the company of making false and misleading statements about its dietary supplement targeting insulin resistance.

GOLO LLC's "Release Supplement" is advertised as a natural solution to optimize metabolism and help reverse insulin resistance, which happens when cells do not respond properly to the hormone insulin. The supplement promotes steady weight loss, reduces anxiety and curbs hunger, according to its website.

Insulin resistance is considered an early step toward type 2 diabetes and is also a cardio metabolic risk factor of metabolic syndrome, the complaint...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!